Compound 1722
Identifiers
- Canonical SMILES:
Oc1ccc(cc1O)-c1oc2cc(cc(O)c2c(=O)c1O)N1CCOCC1
- IUPAC name:
2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-7-(morpholin-4-yl)chromen-4-one
- InChi:
InChI=1S/C19H17NO7/c21-12-2-1-10(7-13(12)22)19-18(25)17(24)16-14(23)8-11(9-15(16)27-19)20-3-5-26-6-4-20/h1-2,7-9,21-23,25H,3-6H2
- InChiKey:
QRVYTBLYTRAQEA-UHFFFAOYSA-N
External links
![]() 90643992 |
![]() CHEMBL3288713 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
LEDGF / IN | 6.01 | HIV infectious disease | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 371.10 g/mol | |||
HBA | 8 | |||
HBD | 4 | |||
HBA + HBD | 12 | |||
AlogP | 2.35 | |||
TPSA | 119.69 | |||
RB | 2 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.7050 | Quercetin | DB04216 | |
0.7050 | Myricetin | DB02375 | |
0.7007 | Fisetin | DB07795 | |
0.6547 | Kaempherol | DB01852 | |
0.6187 | Tricetin | DB08230 | |
0.6187 | Luteolin | DB15584 | |
0.6012 | Quercetin-3'-O-phosphate | DB12937 | |
0.6000 | Diosmetin | DB11259 | |
0.5755 | Apigenin | DB07352 | |
0.5646 | Hispidulin | DB14008 | |
0.5598 | 5,7,2���-trihydroxy-6,8-dimethoxyflavone | DB13983 | |
0.5540 | Chrysin | DB15581 | |
0.5454 | Recoflavone | DB12058 | |
0.5402 | Icaritin | DB12672 | |
0.5220 | 2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE | DB07024 |